Welcome to our dedicated page for Silicon Labs SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Silicon Laboratories Inc. (Silicon Labs, NASDAQ: SLAB) SEC filings, offering investors and analysts a primary view into the company’s regulatory disclosures. As a public semiconductor company focused on low-power wireless connectivity and embedded technology, Silicon Labs uses filings such as Forms 10-K, 10-Q, and 8-K to report its financial condition, risk factors, and material events.
In recent Form 8-K filings, Silicon Labs has reported quarterly results and explained its use of non-GAAP financial measures alongside GAAP metrics. These disclosures describe how the company adjusts for items like stock compensation expense, intangible asset amortization, acquisition- and disposition-related items, termination costs and impairments, equity-method investment adjustments, certain interest expense items, and income tax adjustments based on a long-term non-GAAP tax rate. The reconciliations included in these filings help readers understand the relationship between GAAP and non-GAAP results.
Through this SEC filings page, users can review annual reports (Form 10-K) for comprehensive discussions of Silicon Labs’ business, markets, and risks, and quarterly reports (Form 10-Q) for interim financial updates. Current reports (Form 8-K) provide timely information on earnings releases and other material developments. Where applicable, insider transaction reports (Form 4) can be used to track equity transactions by directors and officers.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key sections, explain complex accounting or tax adjustments, and surface important changes across reporting periods. Real-time updates from EDGAR ensure that new Silicon Labs filings appear promptly, helping users quickly locate the information most relevant to their analysis of SLAB stock and the company’s financial reporting practices.
Silicon Laboratories Inc. Chief Accounting Officer Mark D. Mauldin acquired 18 shares of common stock on the issuer’s employee purchase date at a price of $86.46 per share. After this transaction, he directly holds 21,948 common shares.
The shares were acquired through Silicon Laboratories’ 2009 Employee Stock Purchase Plan in a transaction described as exempt under Rule 166-3(c) and Rule 166-3(d), indicating this was a routine, compensation-related purchase rather than an open-market trade.
Silicon Laboratories Inc. senior vice president of worldwide sales and marketing Brandon Tolany acquired 45 shares of common stock on the most recent semi-annual purchase date. The shares were obtained at $86.46 per share through the company’s 2009 Employee Stock Purchase Plan in a transaction described as a grant or award acquisition. After this routine plan-based acquisition, Tolany directly owns 71,095 shares of Silicon Laboratories common stock.
SILICON LABORATORIES INC. Senior Vice President and CFO Dean Warren Butler acquired additional common stock through the company’s 2009 Employee Stock Purchase Plan. He received 152 shares of common stock at $86.46 per share on the most recent semi-annual purchase date, bringing his directly held stake to 50,058 shares. The acquisition is described as a transaction exempt under Rule 166-3(c) and Rule 166-3(d), indicating it is a routine, compensation-related share purchase rather than an open-market trade.
Silicon Laboratories Inc reported a Schedule 13G identifying Vanguard Capital Management as beneficial owner of 1,725,524 shares of Common Stock, representing 5.23% of the class as of 03/31/2026.
The filing states Vanguard has sole voting power for 252,194 shares and sole dispositive power for 1,725,524 shares. The filing clarifies these holdings include securities held by Vanguard funds and certain affiliated business divisions; no single other person holds >5% of the class according to the disclosure.
Silicon Laboratories Inc. held a special stockholder meeting where investors approved the proposed merger with Texas Instruments Incorporated, under which Silicon Labs will become a wholly owned subsidiary of Texas Instruments after closing conditions are met. The merger proposal passed with 25,878,105 votes in favor, 7,467 against and 1,570 abstentions, representing a strong majority of shares present. Stockholders also approved, on a non-binding advisory basis, the compensation tied to the merger for Silicon Labs’ named executive officers. A separate adjournment proposal was rendered moot because a quorum was present and sufficient votes were already received to adopt the merger agreement.
Vanguard Portfolio Management reports beneficial ownership of 2,167,187 shares of Silicon Laboratories Inc. The filing shows Vanguard holds 2,167,187 shares, representing 6.57% of the outstanding common stock as of 03/31/2026. Vanguard reports sole voting power for 28,351 shares and sole dispositive power for 2,167,187 shares, and states these holdings include securities held for Vanguard funds and managed accounts.
Wyatt Christy reported acquisition or exercise transactions in this Form 4 filing.
SILICON LABORATORIES INC. director Christy Wyatt received a grant of 962 restricted stock units (RSUs), each representing one share of common stock. After this award, Wyatt directly holds 9,454 common shares. The RSUs will fully vest on the earlier of the first anniversary of the grant date or one day before the next year’s Annual Meeting of Stockholders.
Silicon Laboratories Inc. director Navdeep S. Sooch received an equity grant through restricted stock units. The award covers 1,226 RSUs, each convertible into one share of common stock. All RSUs vest on the earlier of the first anniversary of the grant date or one day before the next year’s Annual Meeting of Stockholders. After this grant, Sooch directly holds 401,502 shares of Silicon Laboratories common stock, showing this is a routine compensation-related acquisition rather than an open-market purchase.
Sadana Sumit reported acquisition or exercise transactions in this Form 4 filing.
SILICON LABORATORIES INC. director Sumit Sadana received a grant of 962 restricted stock units (RSUs) of common stock at no cash cost. Each RSU represents the right to receive one share of common stock.
The RSUs will vest in full on the earlier of the first anniversary of the grant date or one day before the company’s next Annual Meeting of Stockholders. After this award, Sadana directly holds 9,982 shares of Silicon Labs common stock, reflecting a modest, compensation-related increase in his equity stake.
Richardson Nina reported acquisition or exercise transactions in this Form 4 filing.
Silicon Laboratories Inc. director Nina Richardson received a grant of 962 restricted stock units (RSUs) of common stock. The RSUs entitle her to one share of common stock for each unit, at no purchase price.
The RSUs will vest in full on the earlier of the first anniversary of the grant date or one day before the company’s next Annual Meeting of Stockholders in the following year. After this compensation-related award, Richardson holds 9,505 shares of Silicon Laboratories common stock directly.